Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index
Article type: Research Article
Authors: Vos, Stephanie J.B.a; * | van Boxtel, Martin P.J.a | Schiepers, Olga J.G.a | Deckers, Kaya | de Vugt, Marjoleina | Carrière, Isabelleb; c | Dartigues, Jean-Françoisd; e | Peres, Karined; e | Artero, Sylvaineb; c | Ritchie, Karenb; c; f | Galluzzo, Luciag | Scafato, Emanueleg | Frisoni, Giovanni B.h; i | Huisman, Martijnj; k | Comijs, Hannie C.l | Sacuiu, Simona F.m | Skoog, Ingmarn | Irving, Kateo | O’Donnell, Catherine A.p | Verhey, Frans R.J.a | Visser, Pieter Jellea; q | Köhler, Sebastiana
Affiliations: [a] Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands | [b] Inserm, U1061, Montpellier, France | [c] University Montpellier, U1061, Montpellier, France | [d] University Bordeaux, ISPED, Centre INSERM U1219 – Bordeaux Population Health Research Center, Bordeaux, France | [e] INSERM, ISPED, Centre INSERM U1219 – Bordeaux Population Health Research Center, Bordeaux, France | [f] Faculty of Medicine, Imperial College, London, UK | [g] Population Health and Health Determinants Unit, National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Rome, Italy | [h] University Hospitals and University of Geneva, Geneva, Switzerland | [i] IRCCS Fatebenefratelli, Brescia, Italy | [j] Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands | [k] Department of Sociology, VU University, Amsterdam, The Netherlands | [l] Department Psychiatry and EMGO Institute for Health and Care Research VU University Medical Center, GGZinGeest, Amsterdam, The Netherlands | [m] Institute of Neuroscience and Physiology, Neuropsychiatric Epidemiology Unit, Sahlgrenska Academy, Sahlgrenska University Hospital, Sweden | [n] Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden | [o] School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland | [p] General Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, UK | [q] Department of Neurology and Alzheimer Center, Neuroscience Campus, VU University Medical Center, Amsterdam, The Netherlands
Correspondence: [*] Correspondence to: Stephanie J.B. Vos, PhD, Alzheimer Center Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands. Tel.: +31 43 38 81036; Fax: +31 43 38 84092; E-mail: [email protected].
Abstract: Background: Recently, the LIfestyle for BRAin health (LIBRA) index was developed to assess an individual’s prevention potential for dementia. Objective: We investigated the predictive validity of the LIBRA index for incident dementia in midlife, late life, and the oldest-old. Methods: 9,387 non-demented individuals were recruited from the European population-based DESCRIPA study. An individual’s LIBRA index was calculated solely based on modifiable risk factors: depression, diabetes, physical activity, hypertension, obesity, smoking, hypercholesterolemia, coronary heart disease, and mild/moderate alcohol use. Cox regression was used to test the predictive validity of LIBRA for dementia at follow-up (mean 7.2 y, range 1–16). Results: In midlife (55–69 y, n = 3,256) and late life (70–79 y, n = 4,320), the risk for dementia increased with higher LIBRA scores. Individuals in the intermediate- and high-risk groups had a higher risk of dementia than those in the low-risk group. In the oldest-old (80–97 y, n = 1,811), higher LIBRA scores did not increase the risk for dementia. Conclusion: LIBRA might be a useful tool to identify individuals for primary prevention interventions of dementia in midlife, and maybe in late life, but not in the oldest-old.
Keywords: Aging, dementia, modifiable risk factors, prevention
DOI: 10.3233/JAD-161208
Journal: Journal of Alzheimer's Disease, vol. 58, no. 2, pp. 537-547, 2017